• 52,741+ CME Conference Registrations Sold
  • 158,223+ Medical Conferences
  • 285 Specialties
  • 11,425 Organizers
  • 157,142 Speakers
  • 159 Countries
  • 4,803 Cities
Home  >  Conferences  >  Advances in Prostate Cancer 2020
IPCE : 7.25

Advances in Prostate Cancer 2020

Oct 03, 2020   |   Washington, Dist of Col  United States of America
Organized by : MedStar Health
Specialties : Oncology   |   Radiology   |   Urology   |   Surgery   |   Family Medicine   |   Pathology   |   Internal Medicine and General Medicine   |   Genetics   |   Nuclear Medicine   |   Hospice and Palliative Medicine   |   Surgical Oncology   |   Radiation Oncology   |   Internal Medicine
Register Now
Conference Brochure

Advances in Prostate Cancer 2020 is organized by MedStar Health and will be held on Oct 03, 2020 at The Wink Hotel, Washington, Dist of Col, United States of America.

Target Audience:
Family Medicine, Hospice and Palliative Medicine, Internal Medicine, Medical Genetics and Genomics, Medical Oncology, Nuclear Medicine, Oncology, Palliative Medicine, Pathology, Radiation Oncology, Radiology, Surgery, Urogynecology, Urology

Accreditation: 
This activity was planned by and for the healthcare team, and learners will receive 7.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

Course Description:
This one-day symposium will update participants on recent advances in the diagnosis and treatment of patients with localized and advanced prostate cancer. Expert faculty will deliver state-of-the-art lectures that will include treatment approaches, clinical trials, biologic and genomic factors and future directions. Attendees will have ample time to network with leaders in the field, participate in panel discussions and navigate complicated cases. Key clinical topics will include the use of biomarkers and modern imaging technologies in the management of early stage prostate cancer as well as advances in the multidisciplinary approach to patients with high-risk, locally advanced, relapsed non-metastatic, and metastatic prostate cancer. Applications of new therapeutic agents, cutting edge radiation technology, combined modality strategies and evolving minimally invasive urologic surgical approaches will also be discussed. In addition, recommendations on resources for patients and practicing healthcare providers will be shared including specialized centers of excellence and research, advocacy and special organizational resources in the region. Ample time will be provided during and between sessions for Q & A and meeting with speakers and experts.

Learning Objectives:
Nurse Learning Objectives

• Educate patients and family on the risk, benefits, and peri-procedural management of transperineal biopsy, rectal spacer placement, and retzius-sparing prostatectomy.
• Recognize the different clinical states of advanced prostate cancer (M0, oligometastatic, widely metastatic) and the relevant treatment options for each state.
• Identify the application of genomic testing of tumors in selecting newly approved systemic therapeutic agents.

Pharmacist Learning Objectives
• Identify the diagnostic, prognostic, and monitoring tests for a patient with prostate cancer.
• Explain the different treatment modalities, including surgery, hormonal therapy, chemotherapy, immunotherapy, and radiotherapy, for patients with prostate cancer.
• Discuss the current and emerging treatment options in the management of patients with castration resistant prostate cancer.
• Discuss how to manage potential side effects to patients on hormonal therapy for prostate cancer.

Physician Learning Objectives
• Interpret prostate MRIs in developing treatment strategies for organ-confined prostate cancer.
• Interpret prostate biomarkers in planning treatment for organ-confined prostate cancer.
• Recognize intermediate and high-risk patients who will benefit from brachytherapy.
• Identify intermediate and high-risk patients who will benefit from immunotherapy.
• Recognize intermediate and high-risk patients who will benefit from salvage therapy.
• Distinguish the proper use of early chemohormonal therapy in patients with high-risk and metastatic prostate cancer.
• Recognize intermediate and high-risk patients who will benefit from chemotherapy.
• Recognize intermediate and high-risk patients who will benefit from testosterone replacement.
• Illustrate the benefits of genetic testing for risk stratification in organ-confined prostate cancer.
• Assess the latest guidelines of the National Comprehensive Cancer Network (NCCN)

View All Speaking

Attending

Kakneka Mason
Kakneka Mason

Clinical Pharmacology

Registration Desk

Contact No. : + 202-780-1655
Email:
medstarcme@gmail.com

Registration

Registration Type Last Date Price
Physician - Registration Fee 02 Oct,2020 USD 150.00
Physician Assistant - Registration Fee 02 Oct,2020 USD 75.00
Nurse Practitioner - Registration Fee 02 Oct,2020 USD 75.00
Nurse - Registration Fee 02 Oct,2020 USD 75.00
Allied Health Professional - Registration Fee 02 Oct,2020 USD 75.00
Pharmacist - Registration Fee 02 Oct,2020 USD 75.00
Resident/Fellow - Registration Fee 02 Oct,2020 USD 75.00
Industry - Registration Fee 02 Oct,2020 USD 195.00
  • Drive Walk Transit Bicycle

Venue Address

The Wink Hotel
1143 New Hampshire Ave NW
Washington, Dist of Col, United States of America

Plan Your Travel

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Inn on Putney Road
55.21 miles from venue
, Free Wifi
Price : USD 194.35 Per Night
Charming Studio in Boston Brownstone, #6
50.74 miles from venue
, Free Wifi
Price : USD 0.00 Per Night
Hilton Boston Logan Airport
50.52 miles from venue
Price : USD 207.00 Per Night
Four Seasons Hotel One Dalton Street, Boston
50.51 miles from venue
, Free Wifi
Price : USD 0.00 Per Night
Close

Session Details

Session Topic Start Time End Time Location Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news